Arvinas, Inc is a clinical-stage biopharmaceutical company focused on enhancing the quality of life for patients with severe and life-threatening illnesses.
The company is dedicated to advancing therapies that target and degrade disease-causing proteins, with the ultimate goal of developing effective treatments for a range of debilitating conditions.
Generated from their website's infomation